Research and Treatment

Research & Treatment

During the past 20 years, advances in hemophilia treatment, including recombinant factor therapy, have allowed people with hemophilia to take...
Update, 7/29/2013: The Senate bill now has 14 co-sponsors and passed in the Senate on June 17, 2013. On July...
As CEO of the National Hemophilia Foundation (NHF), I can honestly say this news has been decades in the making...
Editor’s Note: This article was funded through an educational grant from Novo Nordisk.
Update, August 2013: The FDA approved Tivicay® (dolutegravir), manufactured by ViiV Healthcare, a GlaxoSmithKline company. Tivicay is an integrase strand...
This interview was conducted with Eric Mullins, MD, assistant professor, University of Cincinnati Department of Pediatrics. He is a pediatric...
This interview was conducted with Nidra Rodriguez, MD, an assistant professor in the Department of Pediatric Hematology at The University...
Eric Lowe, 31, needed knee replacement surgery 10 years ago. The small-business owner from Noblesville, ­Indiana, has severe hemophilia A...
As baby boomers age, they’ll not only face arthritis, but the possibility of another “itis” with even greater consequence—hepatitis. In...
Reconstructive surgery on people with hemophilia is more challenging because of the added need of assuring coagulation, the increased incidence...
HemAware is conducting a series of interviews with recipients of the NHF-Shire Clinical Fellowship. It is funded through the generous...
HemAware is conducting a series of interviews with recipients of the NHF-Shire Clinical Fellowship. It is funded through the generous...
Chat Icon
Need Information about Bleeding Disorders?
Contact The Neil Frick Resource Center (NFRC)